These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16936471)

  • 1. Clinical perspectives of heart rate slowing for coronary event reduction and heart failure.
    Danchin N; Kadri Z
    Adv Cardiol; 2006; 43():45-53. PubMed ID: 16936471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate reduction by pharmacological If current inhibition.
    Cargnoni A; Ceconi C; Stavroula G; Ferrari R
    Adv Cardiol; 2006; 43():31-44. PubMed ID: 16936470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future directions: what data do we need?
    Tendera M
    Adv Cardiol; 2006; 43():106-111. PubMed ID: 16936476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I; Camm AJ
    Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. If current inhibition: cellular basis and physiology.
    Mangoni ME; Marger L; Nargeot J
    Adv Cardiol; 2006; 43():17-30. PubMed ID: 16936469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate slowing for myocardial dysfunction/heart failure.
    Mulder P; Thuillez C
    Adv Cardiol; 2006; 43():97-105. PubMed ID: 16936475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
    Su JB
    Curr Pharm Biotechnol; 2014; 14(14):1213-9. PubMed ID: 24831809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradine.
    Borer JS
    Adv Cardiol; 2006; 43():54-64. PubMed ID: 16936472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart rate reduction: a potential target for the treatment of myocardial ischaemia.
    Danchin N; Aly S
    Therapie; 2004; 59(5):511-5. PubMed ID: 15648303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.
    Ferrari R; Ceconi C
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):959-73. PubMed ID: 21878041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of I(f) inhibition by ivabradine in cardiology.
    Böhm M; Reil JC
    Drugs; 2007; 67 Suppl 2():43-9. PubMed ID: 17999563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a beta-blocker and an If current inhibitor in rabbits with myocardial infarction.
    Langenbach MR; Schmitz-Spanke S; Brockert M; Schepan M; Pomblum VJ; Gams E; Zirngibl H; Schipke JD
    J Cardiovasc Surg (Torino); 2006 Dec; 47(6):719-25. PubMed ID: 17043621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine: recent and potential applications in clinical practice.
    Riccioni G
    Expert Opin Pharmacother; 2011 Feb; 12(3):443-50. PubMed ID: 21254949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart rate reduction due to selective specific inhibition of the If current opens new possibilities in treatment of basic cardiovascular diseases].
    Chichkanov GG; Tsorin IB
    Eksp Klin Farmakol; 2013; 76(2):37-42. PubMed ID: 23631283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable coronary artery disease: are there therapeutic benefits of heart rate lowering?
    Tanna MS; Messerli FH; Bangalore S
    J Hypertens; 2019 Jun; 37(6):1112-1118. PubMed ID: 30676481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.
    Fox K; Ford I; Steg PG; Tendera M; Ferrari R;
    Lancet; 2008 Sep; 372(9641):807-16. PubMed ID: 18757088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.